ACTRN12613000124730
Recruiting
未知
In preterm infants with bronchopulmonary dysplasia (BPD) would alterations in inspired oxygen concentrations induce changes that would allow chemoreceptor reflex activity and VQ mismatch to be measured
The Ritchie Centre, Monash University0 sites24 target enrollmentFebruary 1, 2013
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- The Ritchie Centre, Monash University
- Enrollment
- 24
- Status
- Recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Preterm infants \< 29 weeks gestation.
- •1\. Healthy preterm infant (\<29 weeks) without BPD
- •Infants with BPD defined as need for oxygen or respiratory support at 36 weeks completed postmenstrual age (PMA).
- •Infants will be further subdivided into
- •2\. Mild BPD (no need for oxygen or respiratory support at 36 weeks PMA but need for either at 28 days of age).
- •3\. Moderate BPD \- need for supplemental oxygen (\<30%) at 36 weeks PMA butself\-ventilating
- •4\. Severe BPD \- need for supplemental oxygen (\>30%) at 36 weeks PMA or needing respiratory support.
- •Infants in Group 1, the healthy preterm infant will be the control group while infants in Groups 2 to 4 with mild/moderate/severe BPD will be in the intervention group
Exclusion Criteria
- •Infants with congenital heart disease
- •Infants with major congenital anomalies
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Pulmonary Outcomes of Bronchopulmonary Dysplasia in Young AdulthoodPremature BirthObstructive Lung DiseaseBronchopulmonary DysplasiaNCT02820818St. Justine's Hospital50
Completed
Not Applicable
Analysis of BPD in Premature Infants With Typical Imaging ChangesBronchopulmonary DysplasiaNCT04163822Wang Jianhui256
Completed
Not Applicable
Outcome of Extremely Preterm Infants Who Received Systemic Postnatal Corticosteroid for Bronchopulmonary DysplasiaBronchopulmonary DysplasiaNCT05055193Hospices Civils de Lyon400
Unknown
Phase 1
The Treatment of Bronchopulmonary Dysplasia by Instillation PS and Mononuclaer Cells in PretermsNeonates PrematureVentilator SupportNCT03855202yangjie320
Withdrawn
Phase 2
Inhaled Budesonide for Non-ventilated Infants at High Risk of Bronchopulmonary Dysplasia: the i-BUD Pilot StudyBronchopulmonary DysplasiaNCT01895075Dr. Michael Dunn